Pfizer, Moderna in focus as Trump demands answers on COVID success

1 week ago 1

Healthcare

Comments

White House Holds COVID-19 Vaccine Summit

Pandemic-era favorites such as Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) will be under scrutiny after President Donald Trump on Monday urged the companies to justify the success of their COVID-19 drugs, a question he said has “ripped apart” the U.S. CDC.

Recommended For You

More Trending News

Read Entire Article

Pfizer, Moderna in focus as Trump demands answers on COVID success

Recommended For You

More Trending News

Related

Synopsys outlines $7.03B–$7.06B FY2025 revenue target as Ans...

U.S. average pump price seen sliding to $2.90/gallon next ye...

Why Walmart’s U.S. CEO says staffing levels will remain stea...

Limoneira outlines $155M real estate distributions and targe...

Albemarle, lithium stocks sink as big Chinese mine set to re...

Here are the major earnings before the open Wednesday

U.S. crude stockpiles rose 1.2M barrels last week, API says

Trump wants EU to put large tariffs on China, India in Putin...

Gold inches higher to another record; U.S. inflation data ma...

Earnings Snapshot: Synopsys guides FQ4, FY25 below consensus...

OSR Holdings receives Nasdaq notice for minimum bid price no...

OPENLANE to repurchase 53% of Series A preferred stock for $...

Inspirato receives financial commitments totaling $22 millio...

Quantum Q1 2026 Earnings Preview

Chimera Investment announces pricing of public offering of s...

Fifth Third to manage U.S. Treasury's federal benefits progr...

Heron Therapeutics files $125M mixed securities shelf

Henry Schein announces $750 million share repurchase plan

UWM Holdings upsizes prices $1B offering of 6.25% senior not...

Raytheon awarded $760M U.S. Air Force contract

Trending

Popular

England bowled out inside 25 overs in ODI hammering by South...

Can Poulter help Great Britain and Ireland to famous Walker ...